R. Stahel
Impact in
Papers in
-
- Lung Cancer Treatments and Mutations 24
- Lung Cancer Diagnosis and Treatment 12
- Occupational and environmental lung diseases 8
- Pleural and Pulmonary Diseases 6
- Oncology 25
- Lung Cancer Research Studies 15
- Colorectal Cancer Treatments and Studies 7
- Co-authors
- Uwe Zangemeister‐Wittke (7 shared papers)T. Schenker (3 shared papers)Robert Waibel (9 shared papers)L.M. Jost (5 shared papers)A. R. Smith (4 shared papers)Oliver Gautschi (5 shared papers)Gabriella Pichert (2 shared papers)Ana Paula Simões‐Wüst (2 shared papers)
- Journals
- Annals of Oncology (20 papers)Lung Cancer (11 papers)British Journal of Cancer (8 papers)Journal of Clinical Oncology (6 papers)European Journal of Cancer (5 papers)
- Partner nations
- SwitzerlandGermanyFrance
In The Last Decade
R. Stahel
62 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 68
- Oncology 473
- Genetics 111
- Pulmonary and Respiratory Medicine 322
- Immunology 209
- Pathology and Forensic Medicine 162
Countries citing papers authored by R. Stahel
This map shows the geographic impact of R. Stahel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Stahel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Stahel more than expected).
Fields of papers citing papers by R. Stahel
This network shows the impact of papers produced by R. Stahel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Stahel. The network helps show where R. Stahel may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Stahel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 187 | |
| 2 | A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells. | 2000 | 133 |
| 3 | 1998 | 130 | |
| 4 | 1997 | 91 | |
| 5 | 2004 | 37 | |
| 6 | 2007 | 34 | |
| 7 | 1989 | 34 | |
| 8 | 1990 | 28 | |
| 9 | 1995 | 25 | |
| 10 | 1996 | 25 | |
| 11 | 1996 | 24 | |
| 12 | 2015 | 24 | |
| 13 | 2003 | 23 | |
| 14 | Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20. | 1988 | 23 |
| 15 | 1987 | 22 | |
| 16 | 1992 | 18 | |
| 17 | 1992 | 18 | |
| 18 | 2012 | 18 | |
| 19 | 1990 | 17 | |
| 20 | 1994 | 16 |
About R. Stahel
R. Stahel is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (15 papers), Lung Cancer Diagnosis and Treatment (12 papers), Occupational and environmental lung diseases (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Pleural and Pulmonary Diseases (6 papers) and Toxin Mechanisms and Immunotoxins (5 papers). The work is most often cited by research in Oncology (473 citations), Genetics (111 citations), Pulmonary and Respiratory Medicine (322 citations), Immunology (209 citations) and Pathology and Forensic Medicine (162 citations). R. Stahel has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Uwe Zangemeister‐Wittke, T. Schenker, Robert Waibel, L.M. Jost, A. R. Smith, Oliver Gautschi, Gabriella Pichert, Ana Paula Simões‐Wüst, Robert A. Olie and François Natt. Their work appears in journals such as Annals of Oncology, Lung Cancer, British Journal of Cancer, Journal of Clinical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.